EPCA-2 in the early diagnosis of prostate cancer / 中华男科学杂志
National Journal of Andrology
;
(12): 552-555, 2010.
Artículo
en Chino
| WPRIM
| ID: wpr-252784
ABSTRACT
More and more clinical evidence has confirmed the limitations of the use of serum PSA in the screening, detection and treatment of prostate cancer, and scientists are continuously seeking for new biomarkers of the disease. The discovery of early prostate cancer antigen 2 (EPCA-2) has provided a new base for the screening, detection, treatment and follow-up of prostate cancer.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neoplasias de la Próstata
/
Diagnóstico Precoz
/
Diagnóstico
/
Antígenos de Neoplasias
Tipo de estudio:
Estudio diagnóstico
/
Estudio de tamizaje
Límite:
Humanos
/
Masculino
Idioma:
Chino
Revista:
National Journal of Andrology
Año:
2010
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS